Wave Life Sciences Just Edited RNA. Why Its Key Rival, Korro Bio, Skyrocketed.
In this article:
Shares of Wave Life Sciences surged Wednesday after the company announced "impressive" proof-of-concept results for its new technology.
Advertisement
Some parts of this page are not supported on your current browser version. Please upgrade to a recent browser version.
Shares of Wave Life Sciences surged Wednesday after the company announced "impressive" proof-of-concept results for its new technology.